SKI Market

A+| A| A-|

Indian Indices

Sensex

77,550.25 918.60
( 1.20%)

Global Indices

Nasdaq

47,930.49 -276.32
(-0.57%)

Dow Jones

6,837.38 -8.28
(-0.12%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,596.33 -7.15
(-0.07%)

Forex

USD-INR

92.50 0.06
(0.07%)

EUR-INR

108.05 0.09
(0.08%)

GBP-INR

124.08 0.03
(0.03%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

253

57.87

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

PTL Enterprises standalone net profit rises 6.25% in the September 2025 quarter

Nov 13,2025

Net profit of PTL Enterprises rose 6.25% to Rs 14.78 crore in the quarter ended September 2025 as against Rs 13.91 crore during the previous quarter ended September 2024. Sales remain constant at Rs 16.09 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	16.09	16.09	0
OPM %	91.05	90.93	-
PBDT	19.12	19.87	-4
PBT	18.61	19.35	-4
NP	14.78	13.91	6

77,550.25 918.60 ( 1.20%)

47,930.49 -276.32 (-0.57%)

6,837.38 -8.28 (-0.12%)

56,916.27 1,020.95 (1.83%)

10,596.33 -7.15 (-0.07%)

92.50 0.06 (0.07%)

108.05 0.09 (0.08%)

124.08 0.03 (0.03%)

0.58 0.00 (-0.25%)